EnginZyme
ID: 5313486
Seedtable Score
48
Startups
2
Funding Rounds
3
Investors
$29.26m
Money raised
Recent Funding Rounds
Overview
EnginZyme, based in Stockholm, offers an appealing bio alternative to traditional fossil-based chemical production. By providing sustainable biochemical solutions with lower environmental impact and energy consumption, EnginZyme addresses key concerns in traditional chemical processes, such as environmental harm and high energy use. Their B2B model appeals to industries seeking greener production methods. Supported by investors like Sofinnova Partners, SEB Venture Capital, and Industrifonden, the company is well-positioned for growth in sustainability-focused biotech and health tech sectors. EnginZyme's innovative approach may give it a competitive edge as businesses increasingly prioritize eco-friendly practices.
- Website: https://enginzyme.com
- Business model: b2b
- Company size: 51 - 101 employees
- Headquarters: Stockholm, Sweden
- Founded: 2014
- Social accounts: Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (3)
Funding
Funding series
Funding Series Analysis
The company EnginZyme has raised a total of $29.26m in funding over 2 rounds.
Key Insights:
- Series A: $6.91m
- Series B: $22.35m
EnginZyme Series A (2020, $6M)
$6.91m
EnginZyme Series B (2022, $22M)
$22.35m